Evidence map›Paper›PMID 36474416›Full record

ArticleThe Permanente journal2023

Using Non-Invasive Respiratory Monitoring for COVID-19 Pulmonary Embolism Diagnosis.

Matthew Alonzo, Dicky H Shah, Chunyuan Qiu, Jeffery M Cohen, Shawn R Winnick, Anna Finkelstein, Gonzalo Custodio, Irene H Jo, Jennifer Naughton, Sangita Nicholas and 2 more

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in The Permanente journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 73% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Matthew AlonzoKaiser Permanente Baldwin Park Medical Center, Baldwin Park, CA, USA.
Dicky H ShahKaiser Permanente Baldwin Park Medical Center, Baldwin Park, CA, USA.
Chunyuan QiuKaiser Permanente Baldwin Park Medical Center, Baldwin Park, CA, USA.
Jeffery M CohenKaiser Permanente Baldwin Park Medical Center, Baldwin Park, CA, USA.
Shawn R WinnickKaiser Permanente Fontana Medical Center, Fontana, CA, USA.
Anna FinkelsteinKaiser Permanente Baldwin Park Medical Center, Baldwin Park, CA, USA.
Gonzalo CustodioKaiser Permanente Baldwin Park Medical Center, Baldwin Park, CA, USA.
Irene H JoKaiser Permanente Baldwin Park Medical Center, Baldwin Park, CA, USA.
Jennifer NaughtonKaiser Permanente Baldwin Park Medical Center, Baldwin Park, CA, USA.
Sangita NicholasKaiser Permanente Baldwin Park Medical Center, Baldwin Park, CA, USA.
John LeeKaiser Permanente Baldwin Park Medical Center, Baldwin Park, CA, USA.
Vimal DesaiKaiser Permanente Baldwin Park Medical Center, Baldwin Park, CA, USA.
Kaiser Permanente Baldwin Park Medical Center · USKaiser Permanente Fontana Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the high incidence rate of pulmonary embolism (PE) and pneumonia reported in hospitalized patients with COVID-19, the ability to determine the dominant etiology for severe respiratory distress quickly and accurately is crucial to a patient's well-being. Traditionally, D-dimer blood tests and diagnostic imaging studies would be utilized to determine the presence of a PE or a venous thromboembolism. However, COVID-19 places patients in a prothrombotic state and performing diagnostic imaging studies on all patients with COVID-19 would be impractical, making the need for a simple and reliable method to determine the likelihood of PE or venous thromboembolism a priority for emergency departments. The authors believe the use of non-invasive respiratory monitoring technology to assess lung function in hospitalized patients with COVID-19 can aid in discerning the dominant hypoxia etiology and tailoring of their treatment. Here, the authors outline a case and method of using non-invasive respiratory monitoring of lung function in the successful diagnosis of a PE in a 62-year-old patient with COVID-19.

Indexed as

COVID-19Pulmonary EmbolismVenous ThromboembolismCausalityCOVID-19 TestingFibrin Fibrinogen Degradation ProductsHumansMiddle AgedFibrin Fibrinogen Degradation ProductsCase ReportCOVID-19PneumoniaPulmonary Embolism

Identifiers

PMID36474416
PMCPMC10013721
OpenAlexW4311847267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.